Several peptidase inhibitors have been characterised and studied in human diseases, such as acquired immune deficiency syndrome (AIDS), Alzheimer’s, osteoporosis, cardiovascular diseases, rheumatoid arthritis, cancer, obesity, and others12,.39–42. This evidence concerns the gene LAP3 and cancer.